Follow
Shambhavi Borde
Shambhavi Borde
Verified email at purdue.edu
Title
Cited by
Cited by
Year
Ternary solid dispersions: classification and formulation considerations
S Borde, SK Paul, H Chauhan
Drug Development and Industrial Pharmacy 47 (7), 1011-1028, 2021
212021
Formulation and characterization of ternary amorphous solid dispersions of a highly potent anti-tubercular agent and curcumin
S Borde, P Hegde, P Prathipati, J North, D Kumari, H Chauhan
Journal of Drug Delivery Science and Technology 64, 102564, 2021
102021
Investigating crystallization tendency, miscibility, and molecular interactions of drug–polymer systems for the development of amorphous solid dispersions
F Meng, SK Paul, S Borde, H Chauhan
Drug Development and Industrial Pharmacy 47 (4), 579-608, 2021
42021
Metabolic adaptation of NK cell activity and behavior in tumors: challenges and therapeutic opportunities
S Borde, S Matosevic
Trends in Pharmacological Sciences, 2023
32023
synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy
KB Lupo, X Yao, S Borde, J Wang, S Torregrosa-Allen, BD Elzey, ...
Nature Communications 15 (1), 1909, 2024
2024
1206 Immunometabolic modulation of engineered iPSC-NK cells for immunotherapy of solid tumors
S Borde, S Matosevic
Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023
2023
Liquid ready-to-use formulation of levothyroxine
PS Akasapu, R Kalhapure, MV Shah, S Borde, V Subramanian, ...
US Patent 11,400,068, 2022
2022
Solid Dosage Forms: Formulation and Characterization
S Borde, D Singh, N Sharma, D Kumari, H Chauhan
Handbook of Space Pharmaceuticals, 81-95, 2022
2022
Development of Amorphous Ternary Solid Dispersions of a Novel Anti-Tubercular Indole-2-Carboxamide Derivative with Curcumin/Clofazimine for Tuberculosis Treatment
S Borde
Creighton University, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–9